These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 3141542)
1. Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu. Kuruganti U; Henderson LA; Garner RE; Asofsky R; Baker PJ; Domer JE J Leukoc Biol; 1988 Nov; 44(5):422-33. PubMed ID: 3141542 [TBL] [Abstract][Full Text] [Related]
2. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro. Gordon J; Murgita RA; Tomasi TB J Immunol; 1975 Jun; 114(6):1808-12. PubMed ID: 805179 [TBL] [Abstract][Full Text] [Related]
3. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody. HayGlass KT; Naides SJ; Benacerraf B; Sy MS J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody. Nossal GJ; Pike BL; Battye FL Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040 [TBL] [Abstract][Full Text] [Related]
6. Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans. Garner RE; Kuruganti U; al-Hussaini LA; Czarniecki CW; Domer JE Infect Immun; 1992 May; 60(5):1927-35. PubMed ID: 1563784 [TBL] [Abstract][Full Text] [Related]
7. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208 [TBL] [Abstract][Full Text] [Related]
8. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance. Gause A; Yoshida N; Kappen C; Rajewsky K Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044 [TBL] [Abstract][Full Text] [Related]
9. B lymphocyte subpopulation defined by a rat monoclonal antibody, 14G8. Kung JT; Sharrow SO; Ahmed A; Habbersett R; Scher I; Paul WE J Immunol; 1982 May; 128(5):2049-56. PubMed ID: 6801129 [TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with rabbit anti-mouse mu-chain antibody alters the characteristic immunoglobulin heavy-chain restriction of murine suppressor T-cell factors. Sy MS; Lowy A; HayGlass K; Janeway CA; Gurish M; Greene MI; Benacerraf B Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3846-50. PubMed ID: 6233614 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. Sacks DL; Scott PA; Asofsky R; Sher FA J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400 [TBL] [Abstract][Full Text] [Related]
12. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. Scott P; Natovitz P; Sher A J Immunol; 1986 Aug; 137(3):1017-21. PubMed ID: 3487581 [TBL] [Abstract][Full Text] [Related]
13. The abnormal function of T cells in chronically anti-mu-treated mice with no mature B lymphocytes. Kim KJ; Rollwagen F; Asofsky R; Lefkovits I Eur J Immunol; 1984 May; 14(5):476-82. PubMed ID: 6233161 [TBL] [Abstract][Full Text] [Related]
14. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V; Kumar L; Subbarao B J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794 [TBL] [Abstract][Full Text] [Related]
15. The B lymphocyte is the immune cell target for 2',3'-dideoxyadenosine. Cao W; Sikorski EE; Fuchs BA; Stern ML; Luster MI; Munson AE Toxicol Appl Pharmacol; 1990 Sep; 105(3):492-502. PubMed ID: 2237921 [TBL] [Abstract][Full Text] [Related]
16. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses. Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330 [TBL] [Abstract][Full Text] [Related]
17. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. Janeway CA; Ron J; Katz ME J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626 [TBL] [Abstract][Full Text] [Related]
18. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Carrow EW; Domer JE Infect Immun; 1985 Jul; 49(1):172-81. PubMed ID: 4008047 [TBL] [Abstract][Full Text] [Related]
19. Effects of cyclophosphamide on murine candidiasis. Moser SA; Domer JE Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413 [TBL] [Abstract][Full Text] [Related]
20. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population. Finkelman FD; Mond JJ; Metcalf ES J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]